Research ignoring drug prices is an ethical strikeout, Center Faculty Spencer Phillips Hey, PhD, argues in the Journal of Bioethical Inquiry. Ignoring the future price of a drug during the research process is in tension with all three of the major principles of research ethics: it fails to show respect for the research participants, undermines the quality of risk/benefit judgements made by ethical review committees, and makes it impossible to judge future patient access and assess justice.

Read the full article